Pharma Manufacturing and Quality Conference

The soaring population and the government’s initiatives to provide best healthcare infrastructure to its people has led to creation of immense opportunities for the growth and development of the pharmaceutical manufacturing in Saudi Arabia.

With the upliftment of pharmaceutical industry being a key inclusion in the National Transformation Programme (NTP) 2020 to achieve the Kingdom’s Vision 2030 goals, the pharmaceutical manufacturing sector in the Saudi Arabia is poised for tremendous growth.

Recent industry reports indicate that the NTP is aiming for an increase in the role of local pharmaceutical manufacturing in the domestic market, from 18 to 40 percent of the market, and the pharmaceutical market in KSA is projected to expand by 10 percent annually between 2015 and 2020, to reach $13.6 billion.

Report also note that the Saudi Ministry of Health plans to spend $18.5 billion on health care annually over the next 10 years, with a focus on improving the domestic manufacturing of medical devices and pharmaceuticals.

It is against this dynamic background that Messe Frankfurt Middle East in partnership with ACE Exhibitions is launching the Pharma Manufacturing and Quality Conference (PMQC) in Riyadh, KSA.

To be held on 9 to 11 September 2018 in Riyadh, the PMQC 2018 features two days of main conference and a one day post-conference workshop.

Bringing together government authorities, local and international drug manufacturers, and pharmaceutical manufacturing solution providers, the event will be an ideal platform to learn and get first hand insights into implementing best manufacturing practices, facilities and quality standards to improve stability and increased production of drugs in the region.

Key Conference Learning Objectives::

• Current and future trends in the global pharma manufacturing market and new emerging opportunities in the region
• Latest cGMP requirements for drug products in KSA to ensure compliance with the regional and global standards
• Deploying systems to assure proper design, monitoring, and control of pharmaceutical manufacturing processes and facilities
• Optimal roadmap and innovative techniques for successful implementation of lean and six sigma in pharma manufacturing
• Determining and overcoming the scale up challenges in APIs and formulations to ensure flawless large scale manufacturing and swift commercialisation … and more

Who Should Attend?

VPs, Directors, Heads and Managers of:

  • Manufacturing (API and Formulations)
  • Production Operations
  • Plant and Facility design
  • Quality Control and Assurance
  • Technology transfer
  • Process development
  • Automation
  • Third party manufacturing/ Contract manufacturing
  • Regulatory Affairs

From (Industries Involved):

  • Pharmaceutical
  • Drug Manufacturers
  • Active Pharmaceutical Ingredients
  • Universities
  • Research Institutes
  • Contract Manufacturers
  • Professional Associations
  • Pharmaceutical Packing
  • Supply Chain